2m 2m 2m 2m 2m 2m 2m
ENLIVEN THERP (ELVN)
NASDAQ
$54.33+$0.005 (+0.009%)
Price as of Sep 11, 2026 7:56 PM EDT- $4.0BMarket Cap
- 172.14%1-Year Change
- BiotechnologyIndustry
ENLIVEN THERP (ELVN)
$54.33+$0.005 (+0.009%)
ELVN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $54.32 | ||
Change | -$1.91 (-3.40%) | ||
Open | $57.00 | ||
High | $57.00 | ||
Low | $54.12 | ||
Previous Close | $56.23 | ||
Volume | 995,816 | ||
30-Day Average Volume | 850,203 | ||
1-Week Change | -8.43% | ||
1-Month Change | -7.59% | ||
1-Year Change | 172.14% | ||
3-Year Change | 225.85% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 73.3M | ||
Total Assets | $910.2M | ||
Market Cap | $4.0B | ||
Enterprise Value | $3.8B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$32.5M | ||
Free Cash Flow | -$18.6M | ||
EBIT | -$32.5M | ||
EBITDA | -$32.5M | ||
Net Working Capital | $893.2M | ||
EPS | -$0.49 | ||
Enterprise Value/EBITDA | -118 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -111 | ||
PEG | 4 | ||
Price/Free Cash Flow | -214 | ||
Price/Operating Cash Flow | -215 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue